The Documentary Podcast Folgen

Early on a Sunday morning in February in the Spanish seaside town of Benalmadena, Catalina, a 48-year-old mother of four, was killed at home – the building was set on fire. Her ex-partner was arrested and remains in custody. In January, Lina – as she was known to her family and friends – had reported her ex-partner to the police for ill-treatment and threatening behaviour. And by doing so, she became one of around 100,000 cases of gender-based violence active in Spain’s VioGen system.VioGen is an algorithm used by the police – it’s a risk assessment tool. Based on a woman’s answers to a series of questions, it calculates the likelihood she will be attacked again so police resources can be allocated to protect those most in danger. The level of risk could be negligible, low, medium, high or extreme. Lina was recorded as being at ‘medium’ risk of a further attack by the man who was her ex-partner. Three weeks later, she was dead. VioGen’s critics are concerned about the number of women registered on the system who are then murdered by men who are former or current partners. Its champions claim that without VioGen there would be far more violence against women.With AI in the ascendency, and governments increasingly turning to algorithms to make decisions affecting society, for Crossing Continents, Linda Pressly and Esperanza Escribano investigate the story of VioGen and domestic violence in Spain.

Mika Obanda is a Kenyan artist who creates vibrant and personal mosaics using egg shells sourced from local hotels. Cleaning, drying and colouring them, before painstakingly placing each individual tiny piece onto his canvases. Frenny Jowi visits him in his studio in the Nairobi slum of Mukuru as he works on his latest collection. It is a series called Trying to Blossom, in which he often places himself at the centre of his art works, showing not only his own journey as an artist and a person, but also as an activist, reflecting spirituality, love and the wider issues facing himself and his community.

Journalist Kathleen McLaughlin investigates the multi-billion dollar global plasma industry. Kathleen needs $15,000-a-dose medication to treat her rare autoimmune condition. While she sits for hours at a time, just down the block is one of over 1,000 blood donation centres in the USA extracting plasma, which forms an essential part of her treatment. Kathleen investigates the origins of her plasma-based medication and learns why people are resorting to plasma donation to stay out of debt, who is profiting from this booming trade and why the burden of global production is rooted in the US.